medigraphic.com
SPANISH

Revista Cubana de Oftalmología

ISSN 1561-3070 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2017, Number 1

<< Back Next >>

Rev Cub Oftal 2017; 30 (1)

Clinical improvement after use of intraductal probing in the Meibomian gland dysfunction

Cárdenas DT, Hernández LI, Guerra AM, Cruz ID, Montero DE, Hernández FY
Full text How to cite this article

Language: Spanish
References: 0
Page: 1-12
PDF size: 107.82 Kb.


Key words:

Melbomian glands, dysfunction, intraductal probing.

ABSTRACT

Objective: to compare the symptoms experience by the patient (light sensitivity, eye irritation or pain, blurred vision and low vision) before and after use of the intraductal probing. Methods: a prospective, longitudinal and descriptive study conducted in 50 eyes (25 patients) diagnosed with Meibomian gland dysfunction and treated with intraductal probing at "Ramon Pando Ferrer" Cuban Institute of Ophthalmology from March 2014 to March 2015. Results: average age was 47.12 ± 11.49 years and females were slightly predominant (64 %). One week before treatment, the patients presented with light sensitivity, feeling of having some gravel in the eyes, reddened eyes or ocular pain, blurred vision and low vision which were affecting them "part of time" or "all the time". One week after probing, there were no answers "all the time" except for blurred vision and low vision. One month, and six months later, the results were similar with answers ranging from "at no time" to "part of time" regarding light sensitivity, feeling of some gravel in the eyes and red eye. As to blurred vision and low vision, the most common answer was " sometimes". Conclusions: intraductal probing improves the symptoms of the patient who face melbonian gland dysfunction since the first week after treatment; it turned to be more evident after the first month and remained for the next six months.





2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cub Oftal. 2017;30